- Home
- MEGL vs GCTK Comparison
MEGL vs GCTK Comparison
Compare MEGL & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MEGL | GCTK |
|---|---|---|
| Founded | 2016 | 2001 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6M | 6.2M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | MEGL | GCTK |
|---|---|---|
| Price | $1.28 | $5.79 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 17.7K | ★ 18.3K |
| Earning Date | 12-11-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,296,394.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.02 | $4.22 |
| 52 Week High | $5.52 | $468.00 |
Technical Indicators
Market Signals| Indicator | MEGL | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 45.45 | 48.99 |
| Support Level | $1.22 | $4.74 |
| Resistance Level | $1.34 | $6.90 |
| Average True Range (ATR) | 0.07 | 0.38 |
| MACD | 0.01 | 0.13 |
| Stochastic Oscillator | 50.00 | 48.61 |
Price Performance
Historical ComparisonAbout MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.